Actively Recruiting
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2022-07-15
500
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Today the standard for the diagnosis and monitoring of bladder tumors is bladder endoscopy. The performance of this exam is not perfect. With this work, based on artificial intelligence, the investigators wish to combine endoscopy with a complementary diagnostic tool in order to improve patient care. The main objective will be to reduce diagnostic errors / wanderings in patients treated or followed for bladder tumors, by imposing a new standard of diagnostic bladder mapping (high PPV and VPN, high precision)(primary purpose diagnostic). The secondary objective will be to homogenize and systematize the descriptive part of the lesions, and to use AI to better characterize tumor aggressiveness. The final objective being to validate a new precision tool (diagnostic companion) essential for developing and standardizing the therapeutic management of bladder tumors (correcting inter-observer heterogeneity). In this project, video frame will be first extracted from our dataset of cystoscopy videos hosted in in the Next Cloud Recherche. Selected medical image will be segmented and analyzed using our pre-trained CNN model with a feature detection algorithm to obtain features. Data will be analyzed on both patient and lesion levels. The study will assess the Bladder-PAD accuracy on the detection of bladder tumors, and its ability to predict tumor risk of recurrence and progression.
CONDITIONS
Official Title
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unifocal primary or recurrent suspected bladder cancer with tumor size less than or equal to 3 cm
- Multifocal primary or recurrent suspected bladder cancer with 5 or fewer lesions each less than or equal to 3 cm
You will not qualify if you...
- More than 5 tumors or any tumor larger than 3 cm
- Suspected muscle-invasive bladder cancer (cT2 or higher) by computed tomography or cystoscopy
- Evidence of distant metastases by computed tomography or magnetic resonance imaging
- Gross hematuria
- Bacillus Calmette-Guerin (BCG) treatment or chemotherapy within 3 months before inclusion, except a single course of chemotherapy immediately after TUR
- Patients who do not consent to use of their data for research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Amiens University Hospital
Amiens, France, 80054
Actively Recruiting
Research Team
F
Fabien SAINT, Pr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here